Cite
HARVARD Citation
Saussele, S. et al. (2018). Discontinuation of tyrosine kinase inhibitor therapy in chronic myeloid leukaemia (EURO-SKI): a prespecified interim analysis of a prospective, multicentre, non-randomised, trial. Lancet oncology. 19 (6), pp. 747-757. [Online].